Pivotal top-line data demonstrate a four-dose series of 20-valent pneumococcal conjugate vaccine candidate (20vPnC), if approved, would provide the broadest serotype coverage of any pneumococcal…
Following strong second quarter results, Bayer’s Fields of Opportunity Technology Showcase highlights cutting-edge technologies and pipeline solutions expected to propel farmer productivity, sustainability, and company…
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as…
Pfizer to acquire Global Blood rectifiers for$5.4 billion to enhance presence in rare hematologyPfizerInc.( NYSE PFE) and Global Blood rectifiers,Inc.( GBT)( NASDAQ GBT) moment blazoned…
Roughly,000 actors 5 times of age and aged will be enrolled in Lyme complaint-aboriginal regions in Europe and theU.S.NEW YORK & SAINT- HERBLAIN, France–( BUSINESS…
Darolutamide now has suggestions in bothnon-metastatic castration- resistant prostate cancer( nmCRPC) for men at high threat of developing metastatic complaint and metastatic hormone-sensitive prostate cancer(…
Eli Lilly and Company( NYSE LLY) blazoned moment the vacuity of a new, citrate-free expression of Taltz ®( ixekizumab) injection 80 mg/ mL. The new…
Phase 1 Tarlatamab Study Showed Encouraging Antitumor exertion With Median Duration of Response of 13 Months in Small Cell Lung Cancer No Approved Treatment Options…
– Gilead Will give up to$ 5 Million in Global Grant Funding to incontinently Support Public Education and Vaccine Hesitancy Dispatches, a Public Policy Response…
• Data from the Phase 3 SPIRIT program showed MYFEMBREE reduced menstrual pain and non-menstrual pelvic pain in premenopausal women with endometriosis, and a loss…
Collaboration to accelerate the development and access of oncology medicines for cancer patients in China Clinical trial programs combining two of Sanofi’s prioritized oncology assets…
Acquisition Includes TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Serious Autoimmune Disease Tavneos Adds to Amgen’s Decades-Long Leadership in Inflammation and Nephrology Amgen (NASDAQ: AMGN) and…